Patients with gastroesophageal reflux disease have a new generic treatment available. Cipla has received the Food and Drug Administration’s blessing for esomeprazole for oral suspension in dosage ...

Generic Nexium Esomeprazole. Select Doses: 20mg 40mg 20mg 30pills. Common use Nexium is a specific inhibitor of a proton pump PPIs of the parietal cells of the mucous layer of stomach. Nexium is used ...

TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...

LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...

Glenmark has received The Food & Drug Administration’s permission for esomeprazole magnesium delayed-release capsules, 20 mg (OTC), which is the generic of Haleon’s Nexium 24 HR Delayed-Release ...

Nexium is AstraZeneca’s top-seller, bringing in $3.8 billion in revenue in 2004. Ranbaxy wants to produce cheap forms of Nexium in 20-and 40-milligram capsule forms. AstraZeneca is already fighting a ...

Esomeprazole (as magnesium trihydrate) 2.5mg, 5mg, 10mg, 20mg, 40mg; per packet; e-c del-rel granules. Triple therapy (w. amoxicillin + clarithromycin) for H. pylori eradication in duodenal ulcer ...

CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...

AstraZeneca (NYSE:AZN) raised its 2014 sales forecast for the second quarter in a row on Thursday, as the delayed arrival of generic copies of its Nexium drug in the United States kept cash flowing ...

Indian drugmaker Dr. Reddy's Laboratories has had its share of run-ins with the FDA over manufacturing problems at a suite of its facilities. Now, the company is pulling bottles of a generic heartburn ...

MUMBAI/LONDON, March 11 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug ...

LONDON (MarketWatch) - AstraZeneca shares lost ground Tuesday after the Anglo-Swedish pharmaceutical said an Indian drugmaker is looking to make a copy of its Nexium heartburn drug. AstraZeneca ...